EDAP TMS SA - Asset Resilience Ratio

Latest as of June 2024: 73.58%

EDAP TMS SA (EDAP) has an Asset Resilience Ratio of 73.58% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does EDAP TMS SA carry for a breakdown of total debt and financial obligations.

Liquid Assets

$60.46 Million
Cash + Short-term Investments

Total Assets

$82.17 Million
All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2000–2023)

This chart shows how EDAP TMS SA's Asset Resilience Ratio has changed over time. See shareholders equity of EDAP TMS SA for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down EDAP TMS SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of EDAP TMS SA.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $60.46 Million 73.58%
Total Liquid Assets $60.46 Million 73.58%

Asset Resilience Insights

  • Very High Liquidity: EDAP TMS SA maintains exceptional liquid asset reserves at 73.58% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

EDAP TMS SA Industry Peers by Asset Resilience Ratio

Compare EDAP TMS SA's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Sigma Healthcare Ltd
AU:SIG
Medical Distribution 0.03%
Ebos Group Ltd
AU:EBO
Medical Distribution 0.00%
Paragon Care Ltd
AU:PGC
Medical Distribution 0.00%
Mayne Pharma Group Ltd
AU:MYX
Medical Distribution 4.00%
Cyclopharm Ltd
AU:CYC
Medical Distribution 1.98%
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Medical Distribution 4.48%
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
Medical Distribution 4.44%
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
Medical Distribution 5.56%

Annual Asset Resilience Ratio for EDAP TMS SA (2000–2023)

The table below shows the annual Asset Resilience Ratio data for EDAP TMS SA.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 95.05% $87.01 Million $91.55 Million --
2019-12-31 0.00% $0.00 $53.07 Million --
2018-12-31 0.00% $0.00 $48.74 Million --
2017-12-31 0.00% $0.00 $46.90 Million --
2016-12-31 0.00% $0.00 $46.59 Million --
2015-12-31 2.59% $1.00 Million $38.58 Million -0.52pp
2014-12-31 3.11% $1.00 Million $32.15 Million -0.61pp
2013-12-31 3.72% $1.00 Million $26.87 Million +0.32pp
2012-12-31 3.40% $1.04 Million $30.44 Million -1.43pp
2011-12-31 4.83% $1.57 Million $32.55 Million +0.60pp
2010-12-31 4.23% $1.52 Million $35.94 Million +1.47pp
2009-12-31 2.76% $1.11 Million $40.38 Million +0.15pp
2008-12-31 2.61% $1.14 Million $43.86 Million +0.19pp
2007-12-31 2.42% $1.09 Million $45.07 Million -0.76pp
2006-12-31 3.18% $1.03 Million $32.47 Million +2.97pp
2002-12-31 0.21% $81.95K $39.82 Million -18.03pp
2001-12-31 18.24% $9.70 Million $53.21 Million -24.82pp
2000-12-31 43.06% $21.71 Million $50.43 Million --
pp = percentage points

About EDAP TMS SA

NASDAQ:EDAP USA Medical Distribution
Market Cap
$130.06 Million
Market Cap Rank
#18282 Global
#4054 in USA
Share Price
$3.47
Change (1 day)
+4.52%
52-Week Range
$1.25 - $4.91
All Time High
$12.49
About

EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU s… Read more